Judi van Diessen - Concepedia

Author

Judi van Diessen

The Netherlands Cancer Institute

Also Known As

J Van Diessen, J van Diessen, J. Van Diessen, J. van Diessen, Judi Van Diessen, Judi van Diessen

Publications

882

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Amsterdam UMC Location University of Amsterdam Oncode Institute

About

Judi van Diessen is an author at The Netherlands Cancer Institute specializing in health sciences, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	3	3	189
2	Medicine	3	3	189
3	Cancer Therapeutics	2	2	144
4	Radiation Therapy	2	2	113
5	Clinical Trials	1	1	76

Judi van Diessen

Publications

351

Citations

H-Index

Page 1

	Year	Citations
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial) Judi van Diessen, Dirk De Ruysscher, Jan‐Jakob Sonke, Radiotherapy and Oncology Pet-boost TrialMedicineMetronomic TherapyClinical TrialsBronchial Neoplasm	2018	76
Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas J.F. Van den Hoek, Karen Bloemendal, Lilly-Ann van der Velden, Cancers	2016	73
Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab Iris Walraven, Michel M. van den Heuvel, Judi van Diessen, Radiotherapy and Oncology Long-term Follow-upRadiation TherapyMedicineCancer TreatmentOncology	2016	68
Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer Rosemarie de Haan, Michel M. van den Heuvel, Judi van Diessen, Clinical Cancer Research	2020	54
Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy Barbara Stam, Erik van der Bijl, Judi van Diessen, Radiotherapy and Oncology Heart FailureRadiation TherapyOverall SurvivalMedicineAdvanced Nsclc Patients	2017	45
5-Oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factors. W. Kortmann, Michiel A. van Agtmael, Judi van Diessen, PubMed	2008	35

Page 1